Editorial: Microbiota in tumors: is it a new hope for treatment?

In recent years, the number of studies that link the microbiome with human health and disease has increased dramatically. The human microbiota has been increasingly recognized as a dynamic and influential component of the host immune system, metabolism, and even cancer biology. Emerging evidence has revealed that alterations in microbial composition can significantly influence the onset of tumors, as well as their progression, and response to specific therapies. These findings pushed the human microbiome into the spotlight as a promising tool for translational cancer research.